Poseida Therapeutics (PSTX) Competitor Comparison
We are evaluating the key criteria listed to compare Poseida Therapeutics (PSTX) against its competitors in the Biotechnology industry.
Market Capitalization
189 / 368Gross Profits
175 / 278Total Revenue
122 / 300EBITDA
234 / 337Free Cashflow
61 / 352Quick Ratio
255 / 357Earnings per Share
150 / 359Dividend yield
0 / 6Total Cash
136 / 358Performance 3 years
175 / 368Performance 5 years
240 / 368Performance 10 years
215 / 368Linearity 3 years
132 / 368Linearity 5 years
240 / 368Linearity 10 years
207 / 368Total Rank
230 / 368Dividend Rank
239 / 368Valuation Rank
132 / 368Piotroski Rank
126 / 368Muliplier Rank
77 / 368Valuation Rank - PSTX ranking 132 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.